VCAM1 and neoplasm: Moreover, we confirmed that tumor VCAM1 reduced CDC42 expression in human CD8 T cells as well (Supplementary Fig. 7e, f), and that led to impaired IFN-γ production (Supplementary Fig. 7g, h).